U.S. Energy Services Stock News

NasdaqGS:REAL
NasdaqGS:REALSpecialty Retail

Can RealReal (REAL) Turn Leadership Changes And Designer Partnerships Into Lasting Brand Advantage?

The RealReal recently expanded its leadership and governance team, adding Fanatics Commerce COO Jennifer McKeehan to its board while appointing Tiffany Stevenson as Chief People Officer and Tom Hanrahan as Chief Revenue Officer, and also saw Niki Leondakis step down from the board as of March 6, 2026. At the same time, luxury designer Alejandra Alonso Rojas chose The RealReal as a partner to extend the life of her certified sustainable garments, underscoring the platform’s role in...
NasdaqGS:DLTR
NasdaqGS:DLTRConsumer Retailing

Dollar Tree (DLTR) Margin Compression To 5.9% Tests Bullish Earnings Narratives

Dollar Tree (DLTR) has just posted its latest FY 2026 numbers, with Q3 revenue of US$4.8b and basic EPS of US$1.20 setting the tone for the year to date. The company has seen quarterly revenue move from US$4.1b in Q2 FY 2025 to US$4.6b in Q1 FY 2026 and US$4.8b in Q3 FY 2026, while basic EPS has ranged from US$0.66 to US$1.47 over the same stretch, giving you a clear read on how sales and earnings are tracking into the back half of the year. With trailing 12 month net income described as high...
NasdaqGS:STOK
NasdaqGS:STOKBiotechs

Why Stoke Therapeutics (STOK) Is Down 11.4% After NEJM Data on Dravet Syndrome Drug - And What's Next

In March 2026, Stoke Therapeutics and Biogen reported New England Journal of Medicine data showing that investigational antisense therapy zorevunersen produced substantial, durable seizure reductions and multi-year cognitive and behavioral improvements in children and adolescents with Dravet syndrome on top of standard anti-seizure medicines, with an overall safety profile the companies describe as generally well tolerated. The publication is important because it presents multi-year...
NYSE:NEU
NYSE:NEUChemicals

How Structural Oversupply In Petroleum Additives At NewMarket (NEU) Has Changed Its Investment Story

Recently, NewMarket Corporation has come under pressure as its core petroleum additives business faces structural oversupply, with global capacity additions outstripping demand and intensifying competition from Chinese exporters. An additional concern for investors is that bearish research has highlighted how NewMarket’s heavy reliance on this challenged segment could weigh on overall profitability despite past diversification efforts. Against this backdrop, we’ll explore how persistent...
NasdaqGS:VFS
NasdaqGS:VFSAuto

VinFast Auto (NasdaqGS:VFS) Loss Deepens In Q3 EPS And Reinforces Bearish Profitability Concerns

VinFast Auto (NasdaqGS:VFS) has just posted another loss making quarter, with Q3 FY 2025 revenue of about ₫18.1 trillion and basic EPS of a loss of ₫10,238.74, set against a trailing twelve month revenue base of roughly ₫67.5 trillion and a cumulative loss of about ₫92.5 trillion. Over recent periods the company has seen quarterly revenue move from about ₫8.7 trillion in Q2 FY 2024 to ₫12.3 trillion in Q3 FY 2024, ₫16.3 trillion in Q1 FY 2025 and now ₫18.1 trillion in Q3 FY 2025, while...
NYSE:WBI
NYSE:WBIEnergy Services

WaterBridge Infrastructure (WBI) Quarterly Loss Despite US$123.25m Revenue Tests Bullish Re Rating Hopes

Latest FY 2025 Earnings Snapshot WaterBridge Infrastructure (WBI) just posted its FY 2025 numbers with third quarter revenue of US$123.25 million and a basic EPS loss of US$0.02, while net income excluding extra items was a loss of US$0.67 million. The company has seen revenue move from US$89.80 million in the third quarter of 2024 to US$123.25 million in the same period of 2025. The trailing twelve month revenue figure in the dataset stands at US$733.30 million with a net loss of US$91.25...
NasdaqGM:TRUP
NasdaqGM:TRUPInsurance

Assessing Trupanion (TRUP) Valuation After New HABRI Partnership On Service Dog Research

Trupanion (TRUP) shares are in focus after the Human Animal Bond Research Institute announced a new partnership with the pet insurer, centering on research and support for service dogs and the broader human animal bond. See our latest analysis for Trupanion. Despite the HABRI partnership highlighting Trupanion's role in supporting the human animal bond, the stock has faced selling pressure, with a 90 day share price return of 32.03% decline and a 1 year total shareholder return of 31.47%...
NYSE:CRBG
NYSE:CRBGDiversified Financial

Corebridge Financial (CRBG) Is Down 7.0% After Dividend Hike Amid Private Credit Concerns - Has The Bull Case Changed?

In recent days, Corebridge Financial has faced sector-wide pressure as concerns about private credit stability, tighter lending to private credit providers, and fund redemption limits prompted investors to reassess risk across financial companies. At the same time, Corebridge Financial increased its dividend by 4% for shareholders of record as of March 17, 2026, signaling management’s emphasis on returning capital despite heightened market scrutiny of its private credit exposure and cash...
NYSE:TTC
NYSE:TTCMachinery

How Strong Q1 Results And Higher 2026 Sales Guidance At Toro (TTC) Have Changed Its Investment Story

Earlier this month, The Toro Company reported first-quarter fiscal 2026 results showing sales of US$1,036.3 million and net income of US$67.9 million, and management raised full-year 2026 net sales growth guidance to a range of 3% to 6.5%. Management attributed the stronger performance and confidence in higher guidance to robust demand for snow and ice products, contributions from recent acquisitions, and progress on cost-saving initiatives such as the AMP productivity program. Next, we’ll...
NYSE:PARR
NYSE:PARROil and Gas

Par Pacific Holdings (PARR) Sees Barclays Boost Stake: What Does Rising Institutional Interest Really Signal?

In March 2026, Par Pacific Holdings attracted increased attention as Barclays PLC raised its stake by almost one-quarter, while multiple brokerage firms maintained an “Outperform” consensus rating on the company. This combination of higher institutional ownership and supportive analyst views highlights growing institutional engagement with Par Pacific’s refining and fuel distribution footprint in Hawaii and the Rocky Mountain region. We’ll now explore how rising institutional ownership,...
NasdaqGM:ORKA
NasdaqGM:ORKABiotechs

Is Oruka Therapeutics’ (ORKA) ESOP Shelf Registration Quietly Redefining Its Funding Playbook?

Oruka Therapeutics, Inc. recently reported fourth-quarter 2025 results showing a net loss of US$29.58 million and a full-year 2025 net loss of US$105.43 million, alongside narrowing quarterly loss per share from continuing operations to US$0.45. On the same day, the company filed a US$115.44 million shelf registration for 3,354,715 ordinary shares tied to an ESOP-related offering, highlighting its focus on funding flexibility while advancing mid-stage trials for ORKA-002 in psoriasis and...
NYSE:OTIS
NYSE:OTISMachinery

Are Otis (OTIS) Viva Upgrades Quietly Redefining Its Service And Modernization Advantage?

Earlier in March 2026, Otis Worldwide introduced its Viva solutions, a suite of elevator upgrades and features designed to improve safety, accessibility and comfort for aging populations, while also coming standard on its Gen3 and Gen360 systems across major global markets. The focus on intergenerational mobility and retrofit-friendly upgrades positions Viva as a way for building owners to extend asset life, meet evolving accessibility standards and enhance passenger experience without full...
NYSE:RBA
NYSE:RBACommercial Services

A Look At RB Global (RBA) Valuation After Announcing US$500 Million Share Buyback Program

RB Global (RBA) has put a new US$500 million share repurchase plan on the table, targeting up to 10,000,000 shares. The move immediately shifts attention to capital allocation and shareholder returns. See our latest analysis for RB Global. The buyback news comes after a softer period for the shares, with a 7 day share price return of 6.72% and a 90 day share price return of 5.29%. In contrast, the 3 year total shareholder return of 99.05% and 5 year total shareholder return of 91.35% indicate...
NYSE:KWR
NYSE:KWRChemicals

A Look At Quaker Chemical (KWR) Valuation After Recent Share Price Weakness

Quaker Chemical (KWR) has been drawing attention after a period of weaker share performance, with the stock down about 34% over the past month and 14% over the past 3 months. See our latest analysis for Quaker Chemical. Looking beyond the recent slump, Quaker Chemical’s 30-day share price return of 33.95% and year to date share price return of 14.76% contrast with a 1-year total shareholder return of 4.99% and a 5-year total shareholder return of 48.90%. This suggests that shorter term...
NYSE:PUMP
NYSE:PUMPEnergy Services

ProPetro Holding (PUMP) Is Up 17.4% After Profit Return And Crude Spike - Has The Bull Case Changed?

Earlier in March 2026, ProPetro Holding reported quarterly results that beat analyst expectations and showed a move back into profitability, while crude oil prices climbed sharply following renewed attacks on Middle East energy infrastructure that raised concerns about supply disruptions. This combination of stronger operating performance and a supportive commodity backdrop highlighted how closely ProPetro’s prospects are tied to both execution and broader geopolitical tensions in energy...
NYSE:NBR
NYSE:NBREnergy Services

Can Nabors Industries’ (NBR) Strong Q4 Cash Flows Reframe Its Long-Term Risk‑Reward Profile?

Nabors Industries recently reported its fourth-quarter 2025 results, posting adjusted profit of US$0.17 per share and higher operating revenue year over year, driven by stronger contributions from its International Drilling and Drilling Solutions segments. An interesting aspect of this report is how improved free cash flow generation and segment performance have encouraged analysts to revise their estimates upward and assign a more optimistic outlook for the company. Now we’ll examine how...
NYSE:ASAN
NYSE:ASANSoftware

Why Asana (ASAN) Is Down 11.3% After CFO Shift, Buybacks And New AI-Focused Strategy - And What's Next

In early March 2026, Asana announced a series of leadership changes, including a new Chief Financial Officer and Chief Accounting Officer, alongside fourth-quarter and full-year results showing higher revenues and lower net losses, completion of a US$210.6 million share repurchase program, and a new US$97.78 million shelf registration for employee stock offerings. Together with fresh revenue guidance for fiscal 2027 and expanded AI-driven product initiatives, these moves point to an...
NasdaqGS:PDFS
NasdaqGS:PDFSSemiconductor

What PDF Solutions (PDFS)'s Margin Gains and Analytics Pivot Means For Shareholders

Earlier in March 2026, PDF Solutions reported a strong fourth-quarter 2025 performance, with revenue growth and higher gross margins following management’s update on its evolving business model and expanding role in networking and scaled analytics across the semiconductor ecosystem. An interesting angle is how PDF Solutions is increasingly positioning its analytics and networking offerings as core infrastructure for semiconductor supply-chain collaboration and manufacturing...
NasdaqGS:TECH
NasdaqGS:TECHLife Sciences

Bio‑Techne (TECH) Valuation Check After Earnings Beat And Renewed Institutional Interest

Recent quarterly results from Bio-Techne (TECH) came in ahead of earnings and revenue forecasts, and were followed by fresh institutional buying and portfolio additions that put renewed attention on the life sciences supplier. See our latest analysis for Bio-Techne. Despite the upbeat quarter and renewed institutional interest, the 30 day share price return of a 15.15% decline and 1 year total shareholder return of an 18.27% loss show momentum has been weak, with pressure building across both...
NasdaqGS:ADPT
NasdaqGS:ADPTLife Sciences

Adaptive Biotechnologies (ADPT) Is Down 11.9% After MRD-Led Earnings Beat And Tax-Driven Insider Sales - Has The Bull Case Changed?

In March 2026, Adaptive Biotechnologies reported fourth-quarter 2025 results that beat analyst expectations, with revenue growth led by its Minimal Residual Disease (MRD) business, while several senior executives sold shares largely to cover tax obligations linked to vested equity awards. This combination of stronger MRD performance and insider sales tied mainly to tax withholding offers insight into how operational momentum and routine executive transactions can coexist without necessarily...
NYSE:BCC
NYSE:BCCTrade Distributors

Does Boise Cascade’s (BCC) Lean Inventory Strategy Hint at Lasting Efficiency Gains or Hidden Constraints?

Recently, Boise Cascade reported quarterly earnings and revenue that came in ahead of analyst expectations, even as it faced typical seasonal softness and broader market headwinds in its building products markets. The company also highlighted progress on its Thorsby i-line expansion, disciplined operational controls, and lean channel inventories, which together point to a tighter, more efficient operating base for its engineered wood and distribution businesses. Next, we'll examine how this...
NYSE:RVLV
NYSE:RVLVSpecialty Retail

Will Revolve Los Angeles Launch Redefine Revolve Group’s (RVLV) Luxury Brand Narrative?

In March 2026, Revolve Group, Inc. launched Revolve Los Angeles, its first namesake fashion house, debuting a XXS–XL collection priced around US$200–US$3,500 and sold exclusively on Revolve and FWRD. The move expands Revolve’s in-house brand portfolio into higher-end, couture-influenced ready-to-wear, potentially deepening customer engagement around luxury, Los Angeles-inspired fashion. Next, we’ll examine how Revolve Los Angeles, as a higher-end in-house label, could influence Revolve...
NYSE:HESM
NYSE:HESMOil and Gas

Did Hess Midstream’s (HESM) Debt-Funded Buyback Just Redefine Its Capital Return Strategy?

Earlier this month, Hess Midstream LP announced that its Board authorized a share repurchase program and entered into an agreement with JPMorgan Chase Bank to buy back up to US$42 million of Class A shares, funded through its existing revolving credit facility, with repurchased shares to be cancelled and final settlement expected by March 2026. This accelerated share repurchase arrangement not only reduces the public float but also underscores management’s willingness to use balance sheet...
NasdaqGM:AMAL
NasdaqGM:AMALBanks

What Amalgamated Financial (AMAL)'s In-Line Q4 Earnings and Insider Sales Mean For Shareholders

On March 10, 2026, Amalgamated Financial Corp reported fourth-quarter 2025 earnings with earnings per share of $0.91, matching analyst expectations, while quarterly revenue of $87.91 million modestly exceeded forecasts. On the same day, Executive Vice President and Chief Legal Officer Mandy Tenner sold 776 shares under a Rule 10b5-1 plan, adding to a year of insider selling that raises questions about how leadership is managing personal holdings alongside solid operating results. Next,...